+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years +
FEMALE
ID06705075

Study of Contrast Enhanced Ultrasound and Pressure Estimation to Evaluate Uterine Fibroids Before and After Uterine Artery Embolization in Women

Led by Thomas Jefferson University · Updated on 2025-04-10

80

Participants Needed

1

Research Sites

4 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying uterine fibroids in women undergoing uterine artery embolization UAE to better understand blood flow patterns and tissue pressure changes before and after treatment. This study evaluates the use of contrast-enhanced ultrasound CEUS as a less costly, real-time, and noninvasive alternative to gadolinium-enhanced MRI. It also investigates subharmonic-aided pressure estimation SHAPE to compare pressures in fibroid tissue versus normal uterine muscle, aiming to identify new biomarkers for diagnosis and treatment. Participants will receive an investigational drug called Perfluten during ultrasound procedures to enhance imaging of uterine fibroids using CEUS and SHAPE before and after UAE treatment. The study is interventional and monitors these imaging techniques over a two-year period to assess changes in fibroid vascularity and pressure. During the study, participants will undergo ultrasound evaluations using Perfluten to monitor fibroid characteristics. Researchers will assess imaging results to measure outcomes related to fibroid blood flow and pressure. Safety and adherence will be monitored throughout the study duration, which extends for two years to capture changes over time after UAE.

CONDITIONS

Brief Title

Evaluation of Uterine Fibroids by CEUS and SHAPE Pre and Post UAE

Research Team

P

Priscilla Machado, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here